Scholar Rock Holding (SRRK) Asset Utilization Ratio (2019 - 2022)
Scholar Rock Holding (SRRK) posted quarterly Asset Utilization Ratio of 0.09 for Q4 2022, up 42.08% year-over-year from 0.06 in Q4 2021, and down 3.02% quarter-over-quarter from 0.09 in Q3 2022.
Analysis
Scholar Rock Holding (SRRK) Asset Utilization Ratio (2019 - 2022) Analysis & Trends
Scholar Rock Holding's Asset Utilization Ratio history runs 4 years deep, the most recent figure standing at 0.09 for Q4 2022.
- In Q4 2022, Asset Utilization Ratio rose 42.08% year-over-year to 0.09; the TTM figure through Dec 2022 stood at 0.09 (up 42.08% YoY), while the FY2022 annual figure was 0.1, up 84.43% from the prior year.
- Asset Utilization Ratio for Q4 2022 stood at 0.09, down from 0.09 in the prior quarter.
- The five-year high for Asset Utilization Ratio was 0.17 in Q1 2022, with the low at 0.04 in Q1 2021.
- The 4-year median for Asset Utilization Ratio is 0.09 (2022), against an average of 0.09.
- The sharpest annual moves came in 2021 and 2022: Asset Utilization Ratio slumped 66.57% in 2021, then soared 311.78% in 2022.
- Scholar Rock Holding's Asset Utilization Ratio stood at 0.11 in 2019, then tumbled by 47.56% to 0.06 in 2020, then grew by 11.8% to 0.06 in 2021, then surged by 42.08% to 0.09 in 2022.
- Business Quant data shows SRRK's Asset Utilization Ratio at 0.09 in Q4 2022, 0.09 in Q3 2022, and 0.12 in Q2 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.78 Bn | 130.92 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 85.50 Bn | 77.51 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn | 0.20 |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | - |
| 6 | BeOne Medicines | 40.04 Bn | 34.94 Bn | 1.53 Bn | 0.69 |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | 0.90 |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - | 0.13 |
| 9 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | 0.54 |
| 10 | Scholar Rock Holding | 7.25 Bn | 7.25 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | 0.09 |
| Sep 30, 2022 | 0.09 |
| Jun 30, 2022 | 0.12 |
| Mar 31, 2022 | 0.17 |
| Dec 31, 2021 | 0.06 |
| Sep 30, 2021 | 0.06 |
| Jun 30, 2021 | 0.05 |
| Mar 31, 2021 | 0.04 |
| Dec 31, 2020 | 0.06 |
| Sep 30, 2020 | 0.12 |
| Jun 30, 2020 | 0.13 |
| Mar 31, 2020 | 0.12 |
| Dec 31, 2019 | 0.11 |
| Sep 30, 2019 | 0.07 |
| Jun 30, 2019 | 0.04 |